Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
207.00    -10.00 (-4.61%)
Bid:
213.00
Ask:
222.00
Spread: 9.00 (4.225%)
Market Cap: £109.29m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Trading Update

30 Oct 2018 07:00

RNS Number : 5809F
Microgen PLC
30 October 2018
 

 

microgen

www.microgen.com

 

30 October 2018

 

TRADING UPDATE

Microgen plc (LSE: MCGN) has continued to make good progress in the second half of the year.

Aptitude Software has achieved further success with its strategically important Aptitude Insurance Calculation Engine ('AICE'), an application which enables insurers to address the requirements of IFRS 17, an accounting standard focussed on insurance contracts and effective for accounting periods commencing on 1 January 2021. Building on the previously announced new business contracts for AICE in the first half of the year, in September the application was licenced to an existing Aptitude Accounting Hub user, a major global reinsurer headquartered in Europe, demonstrating the opportunity to increase Aptitude Software's footprint within existing clients as the suite of Aptitude Software's applications grows. The business has a number of additional very well qualified material opportunities for AICE in Asia, Europe and North America.

Aptitude Software has also made further progress with its Aptitude Lease Accounting Engine ('ALAE'), an application which allows organisations to address the requirements of IFRS 16 / ASC 842, the new lease accounting standards effective for accounting periods commencing on or after 1 January 2019. A number of new business sales for this application, provided as Software as a Service, have been completed in recent months. The leverage of the cloud platform acquired with the 2017 RevStream acquisition to Aptitude Software's core applications continues to be of great benefit to the business. RevStream sales activity remains strong with further sales expected in 2018 to build on the new business successes for this application in the first half of the year.

Microgen Financial Systems has achieved new business success for its leading Microgen 5Series application focussed on the Trust & Fund Administration market. New clients have been secured in both the Caribbean and Europe in the second half of the year with a number of further opportunities being progressed.

The Board expects the Group to meet management expectations for 2018. The outcome has only a limited amount of dependency on new business to be won during the remainder of the year. 

The Board further announces that Simon Baines has stepped down with immediate effect as Chief Executive Officer of Microgen Financial Systems, a board position of Microgen plc. Simon Baines will leave the employment of the Group in April 2019 to pursue other opportunities.

Microgen Financial Systems, as one of the Group's two software businesses, contributed 29% of Microgen plc's 2017 revenue. Philip Wood, Chief Financial Officer of Microgen plc, will assume the role of Acting Chief Executive Officer of Microgen Financial Systems whilst a long term successor for the role is identified for this business. Tom Crawford continues in his role as Chief Executive Officer of the Group's Aptitude Software business.

Information in relation to payments to be made to Simon Baines will be included in a statement on the Company's website in accordance with Section 430(2B) of the Companies Act 2006.

Ivan Martin, Non-Executive Chairman of Microgen plc, commented:

'Simon Baines joined the Group in 2010 to lead the Microgen Financial Systems business. Under his leadership Microgen Financial Systems has developed into a leading provider of software to the Trust & Fund Administration market, overseeing five acquisitions during his tenure. The Board thanks Simon for his contribution to the business and wishes him well for the future.'

Contacts

Ivan Martin, Chairman 0203 880 7100

Philip Wood, Chief Financial Officer 0203 880 7100

Junya Iwamoto, Investec 0207 597 5970

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMMMZGVLLGRZM
Date   Source Headline
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 202610:56 amRNSNotification of Major Holdings
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:27 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20263:10 pmRNSNotification of Major Holdings
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20262:10 pmRNSNotification of Major Holdings
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSFY25 Trading Update and Notice of Results
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202611:34 amRNSNotification of Major Holdings
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20262:36 pmRNSNotification of Major Holdings
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20262:25 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.